Featured
-
ISH Global Hypertension Practice Guidelines
2020-11-16
Information and resources related to the 2020 ISH Global Hypertension Practice Guidelines
-
ISH Committee and Group Membership 2020-2022
2020-11-01
Following our highly successful virtual General Meeting in October the new ISH leadership structure was confirmed for the 2020-2022 period. Membership of the vast majority of Committees has been now ratified. Please see below.
-
ISH Hypertension News
2020-10-28
We are delighted to share with you the October 2020 issue of ISH Hypertension News.
ISH Hypertension News is available online @ http://ish-world.com/news/a/hypertensionnews/, ISSN: 2520-2782
-
Postponement of MMM 2020
It is with reluctance and sadness that, due to the global impact of the COVID-19 pandemic, the May Measurement Month (MMM) Global Project Team has made the decision that MMM20 should not take place this year.
We hope that volunteers will understand and support this decision. We look forward to planning MMM21 together.
Read More 01/04/2020
-
Renin-Angiotensin System Blockers and the COVID-19 Pandemic
Renin-Angiotensin System Blockers and the COVID-19 Pandemic
At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers
A.H. Jan Danser, Murray Epstein, Daniel Batlle
Read More 26/03/2020
-
Joint Meeting ESH-ISH 2020 - NEW DATES
Dear Colleagues,
The organizing committee of the 2020 ESH-ISH Joint Meeting in Glasgow, would like to inform you that in view of the global unprecedented situation related to COVID-19, the ESH-ISH Joint Meeting, has been rescheduled to April 11-14, 2021.
Read More 23/03/2020
-
A statement from the International Society of Hypertension on COVID-19
The International Society of Hypertension (ISH) is aware of concern raised by speculation, which was amplified by the media and which suggested that hypertension (raised blood pressure) increases susceptibility to infection with COVID-19. Further speculation reportedly suggested that two commonly used classes of blood pressure lowering agents (ACE-Inhibitors and Angiotensin Receptor Blockers (ARBs)) may worsen the outcome for those who are infected with COVID-19 (1).
The ISH completely endorses the content of two recent statements made by the Council on Hypertension of the European Society of Cardiology and the European Society of Hypertension (2,3) both of which made clear that there is no good evidence to change the use of ACE-inhibitors or ARBs for the management of raised blood pressure in the context of avoiding or treating COVID-19 infection.
Read More 16/03/2020
-
ISH Awards Announced
New Awards Supported by the ISH Mentoring and Training Committee and the ISH Women in Hypertension Research Committee Announced.
Read More 24/02/2020
-
Fundamentals for Implementing a Hypertension Program in Resource-Constrained Settings
ISH-supported Online Course aims to help program managers and implementers in designing, planning, and implementing a hypertension control program.
Read More 24/02/2020
-
CALL FOR 2020 ISH AWARD NOMINATIONS
Award Nomination Deadline: Sunday 15th March 2020
NOMINATIONS SHOULD BE SENT TO:
Professor George Stergiou, Chair, ISH Awards Committee
c/o THE ISH SECRETARIAT
Email: secretariat@ish-world.comRead More 13/02/2020
-
ISH Partners in Omron Online Academy Hypertension Course
The ISH is pleased to support our educational partner Omron Heathcare in the launch of a new online curriculum on hypertension.
Read More 18/10/2019
-
STRIDE BP: ISH Supported initiative for accurate blood pressure measurement
STRIDE BP provides lists of accurate devices for office, home and ambulatory…
Read More 11/07/2019
-
Professor Maciej Tomaszewski named ISH President - Elect
The ISH is pleased to announce that Professor Maciej Tomaszewski is the President-Elect of the Society. He will take up the Presidential office at the conclusion of the ISH/ESH 2020 meeting in Glasgow
Read More 13/06/2019